Outset Medical, Inc.

Equities

OM

US6901451079

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
2.32 USD +3.11% Intraday chart for Outset Medical, Inc. +13.17% -57.12%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S CI
BTIG Initiates Outset Medical at Buy Rating With $6 Price Target MT
Outset Medical, Inc. Announces Board Changes CI
RBC Reduces Price Target on Outset Medical to $5 From $6, Keeps Sector Perform Rating MT
Transcript : Outset Medical, Inc., Q4 2023 Earnings Call, Feb 21, 2024
Earnings Flash (OM) OUTSET MEDICAL Reports Q4 Revenue $30.5M, vs. Street Est of $30.1M MT
Outset Medical, Inc. Announces Departure of Steve Williamson as Chief Commercial Officer, Effective March 1, 2024 CI
Outset Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Outset Medical, Inc. Reaffirms Earnings Guidance for 2024 CI
North American Morning Briefing : Stock Futures -2- DJ
Outset Medical Shares Drop After RBC Downgrade MT
RBC Downgrades Outset Medical to Sector Perform From Outperform, Slashes Price Target to $6 From $14 MT
Transcript : Outset Medical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM
Outset Medical, Inc. Provides Revenue Guidance for the Year 2024 CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from S&P Healthcare Equipment Select Industry Index CI
Transcript : Outset Medical, Inc. Presents at Bank of America Virtual Home Care Conference 2023, Dec-04-2023 03:00 PM
Morgan Stanley Raises Outset Medical Price Target to $5.50 From $5, Maintains Equal Weight Rating MT
Morgan Stanley Cuts Price Target on Outset Medical to $5 From $19, Maintains Equalweight Rating MT
Transcript : Outset Medical, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (OM) OUTSET MEDICAL Posts Q3 Revenue $30.4M, vs. Street Est of $30.4M MT
Outset Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
North American Morning Briefing : Middle-East -2- DJ
US Equity Markets Close Mixed Friday Amid Banking Sector's Upbeat Earnings MT
Sector Update: Health Care Stocks Advance in Late Afternoon MT
Top Midday Decliners MT
Chart Outset Medical, Inc.
More charts
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.25 USD
Average target price
5.786 USD
Spread / Average Target
+157.14%
Consensus
  1. Stock Market
  2. Equities
  3. OM Stock
  4. News Outset Medical, Inc.
  5. Outset Medical : Morgan Stanley Adjusts Outset Medical's Price Target to $55 from $60, Keeps Equalweight Rating